Labcorp to Speak at the 43rd Annual J.P. Morgan Healthcare Conference
Labcorp (NYSE: LH), a global leader in innovative and comprehensive laboratory services, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company will engage in a fireside chat scheduled for Tuesday, January 14, at 3:45 p.m. Pacific Time.
Interested parties can access a live audio webcast of the discussion through Labcorp's Investor Relations website at ir.Labcorp.com. The session will also be archived for future viewing.
Labcorp (NYSE: LH), un leader globale nei servizi di laboratorio innovativi e completi, ha annunciato la sua partecipazione alla 43ª Conferenza Annuale J.P. Morgan Healthcare. L'azienda parteciperà a una chat informale programmata per martedì 14 gennaio, alle 15:45 ora del Pacifico.
Le parti interessate possono accedere a un webcast audio in diretta della discussione tramite il sito web delle Relazioni con gli Investitori di Labcorp su ir.Labcorp.com. La sessione sarà anche archiviata per una visione futura.
Labcorp (NYSE: LH), un líder global en servicios de laboratorio innovadores y completos, ha anunciado su participación en la 43ª Conferencia Anual de Atención Médica de J.P. Morgan. La empresa participará en una charla informal programada para el martes 14 de enero a las 3:45 p.m. hora del Pacífico.
Las partes interesadas pueden acceder a un webcast de audio en vivo de la discusión a través del sitio web de Relaciones con Inversores de Labcorp en ir.Labcorp.com. La sesión también se archivará para futuras visualizaciones.
Labcorp (NYSE: LH), 혁신적이고 포괄적인 실험실 서비스의 글로벌 선두주자가 제43회 J.P. Morgan Healthcare 컨퍼런스에 참가한다고 발표했습니다. 회사는 1월 14일 화요일 오후 3시 45분 태평양 시간에 예정된 대화형 채팅에 참여할 예정입니다.
관심 있는 분들은 Labcorp의 투자자 관계 웹사이트 ir.Labcorp.com을 통해 실시간 오디오 웹캐스트에 접속할 수 있습니다. 세션은 향후 시청을 위해 아카이브될 예정입니다.
Labcorp (NYSE: LH), un leader mondial dans les services de laboratoire innovants et complets, a annoncé sa participation à la 43e Conférence Annuelle J.P. Morgan Healthcare. L'entreprise participera à une discussion informelle prévue pour le mardi 14 janvier à 15h45, heure du Pacifique.
Les parties intéressées peuvent accéder à un webcast audio en direct de la discussion via le site des Relations Investisseurs de Labcorp à ir.Labcorp.com. La session sera également archivée pour une consultation future.
Labcorp (NYSE: LH), ein globaler Marktführer in innovativen und umfassenden Laborleistungen, hat seine Teilnahme an der 43. jährlichen J.P. Morgan Healthcare-Konferenz bekannt gegeben. Das Unternehmen wird an einem informellen Gespräch teilnehmen, das für Dienstag, den 14. Januar, um 15:45 Uhr pazifischer Zeit geplant ist.
Interessierte Parteien können über die Investor Relations-Website von Labcorp unter ir.Labcorp.com auf ein Live-Audio-Webcast der Diskussion zugreifen. Die Sitzung wird auch für zukünftige Betrachtungen archiviert.
- None.
- None.
A live audio webcast of the fireside chat will be available via the Company Investor Relations website at ir.Labcorp.com and archived for replay.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 67,000 employees serve clients in approximately 100 countries, provided support for
View original content to download multimedia:https://www.prnewswire.com/news-releases/labcorp-to-speak-at-the-43rd-annual-jp-morgan-healthcare-conference-302348325.html
SOURCE Labcorp
FAQ
When is Labcorp (LH) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch Labcorp's (LH) J.P. Morgan Healthcare Conference presentation?
What type of presentation will Labcorp (LH) give at the 2025 J.P. Morgan Healthcare Conference?
Which annual J.P. Morgan Healthcare Conference is Labcorp (LH) attending in 2025?
